Key Takeaways
- Highest growth since IPO: Net sales rose 36% YoY, the fastest quarter in 12 quarters, driven by 31.3% underlying volume growth and broad-based channel momentum.
- Focus categories now dominate revenue: Focus categories grew 40%+ and crossed 80% of revenue (up from ~70% six to seven quarters ago), improving the quality of growth as non-focus categories lagged.
- Margin expansion is structural, not cyclical: EBITDA margin improved 360-410 bps, split between A&P/channel-mix efficiencies and planned operating leverage, with management confident the current ~12.5% range is a sustainable foundation.
- Younger brands hit escape velocity: The Derma Co. became the second INR 1,000+ crores brand, and the rest of the younger portfolio grew 40%+ even excluding it.
- What to watch next quarter: Whether Mamaearth sustains high-teens growth as the base stiffens in H2, the pace of Dr. Sheth's brand-proposition relook, and any new brand entry into the hair color category.
Topline Growth & Volume Dynamics
- Volume-led growth with price tailwind: Underlying volume growth was 31.3%, with the gap to 36% value growth explained by MRP increases (crude-driven) and a mix shift toward higher-priced channels and brands.
- Broad-based channel performance: E-commerce grew 20%+, while general trade and modern trade each grew 40%, showing the offline push is additive rather than cannibalistic.
- Mamaearth growth is same-store, not distribution-led: 80% of the growth delta came from current stores, not outlet expansion, with high-teens growth balanced equally across online and offline channels.
- Brand health leads market share: Spontaneous awareness, top-of-mind recall, brand affinity, and SAH (share at hand) all sit in healthy ranges, with SAH running ahead of market share, signaling room to deepen distribution and strengthen in-store presence.
- Category tailwinds are structural: Face wash, shampoo, sunscreen, and moisturizers all grew more than 20%, and management sees a decade-long runway from India's per capita beauty spend, which remains lower than Bangladesh's.
Varun Alagh: "As a country, our per capita beauty spend is, in fact, one of the lowest in the Asian population. In fact, it is lower than Bangladesh also. There is only one way the per capita spend in this category will go, which is up."
Focus Categories & Portfolio Quality
- Mathematics of focus: Focus categories were ~70% of revenue six to seven quarters ago and grew 40%+, while the remaining 30% grew slower, mechanically lifting the focus-category share past 80% and improving the quality of company growth.
- INR 50,000 crores market, 5% share: Management sees significant headroom to grow over the next three to five years by continuing to premiumize and gain share within focus categories alone, without needing to stretch into adjacencies.
- Product superiority as a moat: Mamaearth Rice Moisturizer won blind testing against competition ahead of winter, and strong clinical results on The Derma Co. and Aqualogica products will be used in consumer communications to demonstrate superiority.
- Inventory health improving: Nielsen-measured inventory turns have improved and stock pressure has declined further, suggesting channel stuffing is not fueling the reported growth.
Varun Alagh: "If you look at the focus categories market, it is still INR50,000 crores in terms of size, and we are about 5% share within the focus categories market. So, a lot more headroom to grow just by focusing on focus categories and continuing to premiumize and gain share is what we can see happening over the next three to five years."
Younger Brands: The Second Engine
- The Derma Co. crosses INR 1,000 crores: The brand sustained strong profitable growth, with consumer love (index searches) near all-time highs and offline outlet reach hitting 65,000 in just four quarters of focus.
- Younger brands ex-TDC grew 40%+: Aqualogica, Dr. Sheth's, BBlunt, Staze, and Reginald Men all demonstrated solid trajectories, with some growth captured via D2C channels within online and not fully reflected in e-commerce channel figures.
- BBlunt hair color at 100%+ YoY: The relaunched hair color portfolio is growing triple digits, the styling category is performing well on quick commerce, and a care-category relaunch (shampoo and conditioners) is planned.
- Aqualogica winning with Gen Z: The brand is gaining in sunscreens, body/fragrant body care, and moisturizers, with top-of-mind spontaneous preference improving among Gen Z consumers.
- Dr. Sheth's at an inflection point: The brand is seeing much larger active-ingredient adoption than originally hypothesized, prompting a relook at the brand proposition to target a higher age cohort, with ranges like Botox and collagen performing well.
- Hair color entry under consideration: Management is watching the category and sees opportunity in safer, toxin-free, natural options, with a potential launch from another brand to be communicated shortly.
Margin Structure & Trajectory
- 360-410 bps EBITDA improvement, two drivers: 250-270 bps came from A&P and mix efficiencies (favorable channel mix shift toward offline and quick commerce, plus improved A&P efficiency across both large and young brands), and 110-140 bps from planned operating leverage.
- Channel mix is a margin tailwind: Higher share of B2B quick commerce and offline trade reduces sales commission on third-party platforms, showing up in other-expenses improvement, and management does not expect a significant mix shift back toward e-commerce at the company level.
- Gross margin held at 70%: Crude cost pressures were absorbed through cost management and price increases, keeping gross margin stable.
- 15% EBITDA is the four-year goal, not a straight line: Management expects some years of exceptional YoY improvement (like the current year) and others of only 50-70 bps if it chooses to double down on growth, with the current ~12.5% range seen as a sustainable foundation.
Varun Alagh: "I mean, I have not seen any benefits of being too aggressive. Conservative probably the better place to be. But yes, structurally, business has done better, and what you're seeing now, that level for us seems to be a foundation that we are very comfortable in maintaining."
Brand-Level Disclosure & Competitive Sensitivity
- Management declined to break out individual brand growth: When asked to strip out The Derma Co., management stated that disclosing brand-level growth is not competitively prudent, but confirmed that even excluding The Derma Co., younger brands are growing at 40% plus.
- Q3 sequential guidance withheld: Asked whether the ~12% sequential growth seen in Q3 of the prior two years can be sustained given the high Q2 base, management would only confirm Q3 will be higher than Q2 sequentially and that YoY growth will remain strong, declining to comment on percentages.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA margin goal | Reach 15% EBITDA margin profile | Over a four-year horizon (no year-wise target) |
| Near-term margin floor | Hold current trajectory in the around 12.5 range | Ongoing |
| Mamaearth growth | Sustain high-teens YoY growth, balanced across online and offline | H2 FY27 and beyond, even as base stiffens |
| Focus category share gain | Grow from ~5% share within the INR 50,000 crores focus-category market by premiumizing and gaining share | Next three to five years |
| Hair color entry | Considering entry into the hair color category from another brand | To be communicated shortly |
| BBlunt care relaunch | Relaunch shampoo and conditioner range to make it more relevant | Planned, no date specified |
| Dr. Sheth's brand repositioning | Relook at brand proposition to target higher age cohort and active-ingredient consumers | Underway |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Net sales growth | 36% YoY, highest growth quarter since listing |
| EBITDA | Doubled YoY |
| EBITDA margin | 12.7% |
| Gross margin | 70%, maintained despite crude cost pressures through cost management and price increases |
| Underlying volume growth (UVG) | 31.3% |
| EBITDA improvement from A&P and mix efficiencies | 250–270 bps YoY |
| EBITDA improvement from operating leverage | 110–140 bps YoY |
| Focus categories revenue contribution | 80%+, up from ~70% six to seven quarters ago |
| Focus categories growth | 40%+ YoY |
| Mamaearth growth | High teens YoY |
| Mamaearth market share gain in face wash | 140 bps (Nielsen measured) |
| Mamaearth market share gain in shampoo | 50 bps (Nielsen measured) |
| Younger brands growth | 45%+ YoY; 40%+ excluding The Derma Co. |
| E-commerce channel growth | 20%+ YoY |
| General trade growth | 40% YoY |
| Modern trade growth | 40% YoY |
| Modern trade offtake growth | 40%+ YoY |
| Mamaearth outlet reach | 3.2 lakh outlets, 26% YoY growth in numeric distribution |
| The Derma Co. outlet reach | 65,000 |
| Mamaearth same-store growth | ~30%+ |
| The Derma Co. Nielsen market share in face washes | ~1.2% |
| BBlunt hair color portfolio growth | 100%+ YoY post relaunch |
| The Derma Co. ARR | ₹1,000 crores plus range |
| Medium-term EBITDA margin aspiration | 15% |